Ms. Tina Celeste Outlaw, BSW,MSW, LISW-CP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2919 Jeffords Rd N, Outlaw's Vision Quest Farm, Inc., Lamar, SC 29069 Phone: 843-857-0298 |
News Archive
Kolltan Pharmaceuticals, Inc., a privately held biopharmaceutical company, today announced a license and research agreement with The Children's Hospital of Philadelphia to commence a collaboration with Yaël Mossé, M.D, an internationally recognized clinician and scientist for her work studying the causes and novel therapeutic approaches for the treatment of children diagnosed with neuroblastoma.
During the first 18 months after treatment with ali-pogene tiparvovec, a gene therapy recently approved in Europe to treat lipoprotein lipase deficiency (LPLD), the first patient to receive the treatment had no abdominal pain or episodes of pancreatitis, following a history of 37 pancreatitis attacks.
More than 11 million children in developing countries die every year from preventable illness, while as many as 500 000 women don't survive during pregnancy or childbirth. More than 39 million people are living with HIV/AIDS and the epidemic is growing.
Appian Labs, LLC, a biopharmaceutical company specializing in advanced therapeutic design and delivery, has announced an exclusive Development and Commercial License Agreement for the company's AppiForm™ Modular Release System with Capsugel, the world's leading provider of dosage form solutions to the pharmaceutical and related healthcare industries. The agreement provides for Capsugel to utilize the AppiForm Modular Release System for customizable drug delivery profiles.
Researchers at the University of California, Berkeley (USA) have now developed a new strategy for the formation of hybrid materials from synthetic polymers and proteins. They have thus been able to fuse the specific biological functions of proteins with the advantageous bulk and processing properties of plastics.
› Verified 2 days ago